CSL, Vifor Vifor International AG (CSL Vifor) Travere Therapeutics, Inc. 07.08.2025 - 18:09:05 CSL Vifor and Travere Therapeutics announce standard EU approval for FILSPARI® in IgA Nephropathy View original content:https://www.prnewswire.co.uk/news-releases/csl-vifor-and-travere-therapeutics-announce-standard-eu-approval-for-filspari-in-iga-nephropathy-302439809.html
